According to researchers at the American Heart Association who presented data from an randomized, double-blind study of 18,144 high-risk patients, it had been found that patients taking Vytorin, a combination of the cholesterol-lowering statin Zocor plus Zetia, a non-statin, experienced fewer heart attacks, strokes and repeat hospitalizations than those who were taking just statins. Lowering … [Read more...]
Merck Recalls Cholesterol Drug Liptruzet
Drugmaker Merck & Co., based in Whitehouse Station, N.J. said on Tuesday that it is recalling all lots of Liptruzet, sweeping out the complete U.S. stock, due to a packaging defect. Liptruzet is combination of the cholesterol-lowering drugs ezetimibe and atorvastatin. Packaging defect can likely let air and moisture affect the quality of the drug. The corporation said“the likelihood of the … [Read more...]